The importance of Cathepsin's-D tissular detection in laryngeal squamous cell carcinoma

Acta Oto-Rhino-Laryngologica Belgica

Volumn 56, Issue 4, 2002, Pages 383-389

  Lentari, I ^a,b,c   Segas, I ^b   Kandiloros, D ^b  

^a Phoniatric Dept ENT Hd/Neck Surg   (Belgium)

^b UNIVERSITY OF ATHENS   (Greece)

^c NONE   (Greece)

Author keywords

Cathepsin D; Laryngeal cancer; Prognosis

Indexed keywords

CATHEPSIN D; TUMOR MARKER;

ADULT; AGED; CANCER RECURRENCE; CANCER SURVIVAL; CONFERENCE PAPER; HUMAN; HUMAN CELL; HUMAN TISSUE; IMAGE ANALYSIS; IMMUNOHISTOCHEMISTRY; LARYNX CARCINOMA; MAJOR CLINICAL STUDY; PROGNOSIS; RETROSPECTIVE STUDY; SQUAMOUS CELL CARCINOMA; STATISTICAL ANALYSIS; STROMA CELL;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; CATHEPSIN D; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; LARYNGEAL NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 0037021735     PISSN: 00016497     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (20)

1. Dolcetti R., Doglioni C., Maestro R. et al. p53 over-expressions an early event in the development of human squamous cell carcinoma of the larynx: Genetic and prognostic indications. Int. J. Cancer, 52: 178-182, 1992.
2. Frachiolla N. S., Pignataro L., Capaccio P. et al. Multiple genetic lesions in laryngeal squamous cell carcinomas. Cancer, 75: 1292-1301, 1995.
3. Brennan J. A., Mao L., Jruban R. H. et al. Molecular assessment of histopathological staging in squamous-cell carcinoma of the head and neck. New Engl. J. Med., 332: 429-435, 1995.
4. Gousia A., Ioachim E., Peschos D. et al. Immunohistochemical expression of cathepsin-D in laryngeal epithelial lessions: Correlation with CD44 expression, p53 and Rb status and proliferation associated incides. Anticancer-Res., 19 (4B): 3055-60, 1999.
5. Schwarz M. K. et al. Tissue cathepsins as tumor markers. Clin. Chim. Acta, 237: 67-78, 1995.
6. Marsigliante S., Resta L., Leo G. et al. Expression of cathepsin-D in malignant and in the corresponding non-malignant node-negative laryngeal samples: Correlation with receptors for androgene, glucocorticoid, oestrogene and progesterone. Cancer Lett., 68: 135-142, 1993.
7. Reid W. A., Valler M. J., Kay J. et al. Immunolocalization of cathepsin-D in normal and neoplastic human tissues. J. Clin Pathol., 39: 1323-1330, 1986.
8. Saku T., Sakai H., Tsuda N. et al. Cathepsins D and E in normal metaplastic, dysplastic and carcinomatous gastric tissue: An immunohistochemical study. Gut, 31: 1250-1255, 1990.
9. Maudelonde T., Khalaf S., Garcia M. et al. Immunoenzymatic assay of Mr 52,000 cathepsin-D in 182 breast cancer cytosols: Low correlation with other prognostic markers. Cancer Res., 48: 462-466, 1998.
10. Graf M., Baici A., Strauli P. et al. Histochemical localization of cathepsin B at the invasion front of the rabbit V2 carcinoma. Lab Invest., 45: 587-596, 1981.
11. Johnson M. D., Torri J. A., Lippman M. E. et al. The role of cathepsin-D in the invasivness of human breast cancer cells. Cancer Res., 53: 873-877, 1993.
12. Tetu B., Brisson J., Cote C. et al. Prognostic significance of cathepsin-D expression in node-positive breast carcinoma: An immunohistochemical study. Int. J. Cancer., 55: 429-435, 1993.
13. Zeillinger R., Eder S., Schneeberger Ch. et al. Cathepsin D and RAI-1 expression in human head and neck cancer. Anticancer Res., 16: 449-454, 1996.
14. Ferrandina G., Scambia G., Benedetti Panici P. et al. Cathepsin D in primary squamous laryngeal tumors: correlation with clinicopathological parameters and receptors status. Cancer Lett., 67 (2-3): 133-138, 1992.
15. Tomasino R. M., Bazan V., Daniele E. et al. Biological characterization of laryngeal squamous-cell carcinoma. Anticancer Res., 16: 1257-1268, 1996.
16. Strojan P., Budihna M., Smid L. et al. Cathepsin D in tissue and serum of patients with squamous cell carcinoma of the head and neck. Cancer Lett., 130 (1- 2): 49-56, 1998.
17. Budihna M., Strojan P., Smid L. et al. Prognostic value of cathepsins B, H, L, D and their endogenous inhibitors stefins A and B in head and neck carcinoma. Biol. Chem. Hoppe Seyler., 377 (6): 385-390, 1996.
18. Gandour-edwards R., Trock B., Donald P. J. et al. Predictive value of cathepsin-D for cervical lymph node metastasis in head and neck squamous cell carcinoma. Head Neck., 21(8): 718-722, 1999.
19. Takes R. P., Baatenburg De Jong R. J., Schuuring E. D. et al. Markers for assessment of nodal metastasis in laryngeal carcinoma. Arch. Otolaryngol. Head Neck Surg., 123: 412-419, 1997.
20. Marsigliante S., Biscozzo L., Resta L. et al. Immunohistochemical and immunoradiometric evaluations of total cathepsin D in human larynx. Eur. J. Cancer B. Oral Oncol., 30B (1): 51-55, 1994.